MarketCap
Genetic Technologies Limited GENE
Facebook
X
Telegram
Land |
 Australien |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITAL |
Anteile |
132 M |
Marktkapitalisierung |
$ 7.1 B |
EBITDA (LTM) |
$ -2.64 M |
P/E (LTM) |
- |
P/S (LTM) |
290.21 |
EPS (LTM) |
5.41 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Guardant Health
GH
|
$ 154.56 | -8.32 % | $ 19.4 B | Nasdaq Global Select Market,SPB |  USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 25.49 | -5.84 % | $ 571 M | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 120.47 | -15.51 % | $ 7.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Agilent Technologies
A
|
$ 171.62 | -3.14 % | $ 48.7 B | NYSE,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 312.54 | -4.19 % | $ 15.5 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.73 | -0.41 % | $ 6.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 363.86 | -6.95 % | $ 49.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 363.12 | -1.26 % | $ 30.2 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 34.15 | -4.49 % | $ 990 M | Nasdaq Global Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 253.91 | -0.69 % | $ 28.2 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 226.89 | -3.44 % | $ 162 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 677.93 | -2.66 % | $ 34.6 B | NYSE,SPB |  Schweiz |
 |
DexCom
DXCM
|
$ 84.0 | -5.06 % | $ 32.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 30.5 | -1.74 % | $ 28.9 B | NYSE |  Niderland |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 78.05 | -2.75 % | $ 5.87 B | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Sotera Health Company
SHC
|
$ 15.87 | -3.2 % | $ 4.51 B | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 10.6 | -5.44 % | $ 360 M | Nasdaq Global Select Market | Israel |
 |
Neuronetics
STIM
|
$ 2.43 | -10.17 % | $ 160 M | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 676.84 | -4.18 % | $ 255 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 5.9 | -8.28 % | $ 2.12 B | Nasdaq Global Select Market |  Irlanda |
 |
VolitionRx Limited
VNRX
|
$ 0.2 | -3.92 % | $ 25.2 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 453.45 | -2.87 % | $ 27 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 7.6 | -10.69 % | $ 164 M | Nasdaq Global Market | USA |
 |
Illumina
ILMN
|
$ 207.8 | -8.27 % | $ 32.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 634.61 | -3.37 % | $ 18.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market |  Britain |